Status:
COMPLETED
Laser Therapy for Patients With Systemic Lupus Erythematosus
Lead Sponsor:
Dr. Merve Benli
Conditions:
Systemic Lupus Erythematosus
Muscle Pain
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease that has detrimental effects on connective tissue and other organs. The musculoskeletal system is one of the most affected systems i...
Eligibility Criteria
Inclusion
- Having myogenic temporomandibular joint disorder,
- Following a stable medical regime,
- Showing minimum pain intensity of 50 mm on the visual analog scale.
Exclusion
- Having concurrent systemic diseases,
- Using antimalarial drugs,
- Wearing removable prosthesis,
- History of facial trauma.
Key Trial Info
Start Date :
January 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2020
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT04453215
Start Date
January 12 2019
End Date
March 15 2020
Last Update
November 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul university,Faculty of Dentistry
Fatih, Turkey (Türkiye), 34452